Inventor · disambiguated record
Raffaella Briante
Also filed as: BRIANTE RAFFAELLA
2 granted patents·9 pending applications·14 citations·filing 2013–2022
50Inventor score
Files withKENJOCKETY BIOTECHNOLOGY INC4COMPUGEN LTD2CYTOMX THERAPEUTICS INC2WILLIAM ROBERT ARATHOON LIVING TRUST DATED AUGUST 29 20162COJOCARU GADY S1
Top patents by PatentIndex Score
11 records- 0184US9617336B2C10RF32 antibodies, and uses thereof for treatment of cancerCOMPUGEN LTD·Filed 2013·Granted Apr 11, 2017·14 cites·23 claims
- 0259US2020002416A1C10rf32 antibodies, and uses thereof for treatment of cancerCOMPUGEN LTD·Filed 2019·Application pending·0 cites
- 0358US2023174995A1Activatable polypeptide complexCYTOMX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0458US2023183382A1Activatable polypeptide complexCYTOMX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0547US2023272117A1Anti abcc1 antibodies and uses thereofKENJOCKETY BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 0647US2025051471A1Anti-Abcb1 AntibodiesWILLIAM ROBERT ARATHOON LIVING TRUST DATED AUGUST 29 2016·Filed 2022·Application pending·0 cites
- 0746US2023212305A1Anti-abcg2 antibodies and uses thereofKENJOCKETY BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 0845US2017233473A1C10rf32 antibodies, and uses thereof for treatment of cancerCOJOCARU GADY S·Filed 2017·Application pending·0 cites
- 0943US2023203156A1Anti-mdr1 antibodies and uses thereofKENJOCKETY BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 1042US2023192902A1Abcg2 efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related theretoKENJOCKETY BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 1131US12331121B2Efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related theretoWILLIAM ROBERT ARATHOON LIVING TRUST DATED AUGUST 29 2016·Filed 2020·Granted Jun 17, 2025·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →